[go: up one dir, main page]

MA27093A1 - Derives de sulfonamides, leur preparation et leur application comme medicaments. - Google Patents

Derives de sulfonamides, leur preparation et leur application comme medicaments.

Info

Publication number
MA27093A1
MA27093A1 MA27723A MA27723A MA27093A1 MA 27093 A1 MA27093 A1 MA 27093A1 MA 27723 A MA27723 A MA 27723A MA 27723 A MA27723 A MA 27723A MA 27093 A1 MA27093 A1 MA 27093A1
Authority
MA
Morocco
Prior art keywords
medicaments
preparation
sulfonamide derivatives
application
processes
Prior art date
Application number
MA27723A
Other languages
English (en)
Inventor
Ramon Marce-Vidal
Blas Andaluz-Mataro
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of MA27093A1 publication Critical patent/MA27093A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632—Organic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)

Abstract

DERIVES DE SULFONAMIDES, LEUR PREPARATION ET LEUR APPLICATION COMME MEDICAMENTS La présente invention concerne de nouveaux dérivés de sulfonamides, de formule générale (I), ainsi que leurs sels physiologiquement acceptables, les procédés pour leur préparation, leur application comme médicaments en thérapeutique humaine et/ou vétérinaire et les compositions pharmaceutiques qui les contiennent.
MA27723A 2001-11-14 2004-06-07 Derives de sulfonamides, leur preparation et leur application comme medicaments. MA27093A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102517A ES2187300B1 (es) 2001-11-14 2001-11-14 Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.

Publications (1)

Publication Number Publication Date
MA27093A1 true MA27093A1 (fr) 2004-12-20

Family

ID=8499446

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27723A MA27093A1 (fr) 2001-11-14 2004-06-07 Derives de sulfonamides, leur preparation et leur application comme medicaments.

Country Status (33)

Country Link
US (4) US7105515B2 (fr)
EP (2) EP1666462B1 (fr)
JP (2) JP4416505B2 (fr)
KR (1) KR20040071685A (fr)
CN (1) CN1271052C (fr)
AR (1) AR037288A1 (fr)
AT (2) ATE428694T1 (fr)
BR (1) BR0214243A (fr)
CA (1) CA2466965C (fr)
CO (1) CO5590895A2 (fr)
CY (1) CY1105362T1 (fr)
DE (2) DE60209779T2 (fr)
DK (1) DK1445252T3 (fr)
EC (1) ECSP045105A (fr)
ES (4) ES2187300B1 (fr)
HR (1) HRP20040429B1 (fr)
HU (1) HUP0402317A2 (fr)
IL (2) IL161885A0 (fr)
IS (2) IS7263A (fr)
MA (1) MA27093A1 (fr)
MX (1) MXPA04004601A (fr)
NO (1) NO20042478L (fr)
NZ (2) NZ543393A (fr)
PL (1) PL373894A1 (fr)
PT (2) PT1666462E (fr)
RS (1) RS41104A (fr)
RU (2) RU2293082C2 (fr)
SG (1) SG146442A1 (fr)
SI (1) SI1445252T1 (fr)
TW (1) TWI275585B (fr)
UA (1) UA78252C2 (fr)
WO (1) WO2003042175A1 (fr)
ZA (1) ZA200404073B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2187300B1 (es) * 2001-11-14 2004-06-16 Laboratorios Del Dr. Esteve, S.A. Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
RU2005138147A (ru) * 2003-05-09 2007-06-27 Лабораториос Дель Др. Эстеве С.А. (Es) Применение сульфонамидных производных для изготовления лекарственного средства, предназначенного для профилактики и/или лечения нарушений потребления пищи
ES2222827B1 (es) * 2003-07-30 2006-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2222829B1 (es) * 2003-07-30 2006-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2228267B1 (es) * 2003-07-30 2006-07-01 Laboratorios Del Dr. Esteve, S.A. Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2222832B1 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2222830B1 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Derivados de 7-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2228268B1 (es) * 2003-07-30 2006-07-01 Laboratorios Del Dr. Esteve, S.A. Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
SE0303480D0 (sv) * 2003-12-19 2003-12-19 Biovitrum Ab Benzofuranes
PT1704154E (pt) * 2004-01-02 2009-08-05 Suven Life Sciences Ltd Novos indeno[2,1a]indenos e isoindol[2,1-a]indóis
ES2246721B1 (es) * 2004-08-10 2007-03-16 Laboratorios Del Dr. Esteve, S.A. Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos.
EP1632491A1 (fr) * 2004-08-30 2006-03-08 Laboratorios Del Dr. Esteve, S.A. composes indole substitues et leur utilisation comme modulateurs du recepteur 5-ht6
US7375219B2 (en) * 2005-04-13 2008-05-20 Neuraxon, Inc. Substituted indole compounds having NOS inhibitory activity
JP5026690B2 (ja) * 2005-11-21 2012-09-12 株式会社ジャパンディスプレイイースト 表示装置
HRP20130058T1 (hr) * 2006-01-24 2013-02-28 Eli Lilly & Company Indolsulfonamidni modulatori progesteronskih receptora
EP1837332A1 (fr) * 2006-03-23 2007-09-26 Laboratorios Del Dr. Esteve, S.A. Tetrahydroquinolines substitués, leur préparation et utilisation comme médicaments
CA2643822A1 (fr) * 2006-04-13 2007-10-25 Neuraxon, Inc Indoles 1,5- et 3,6-substitues a activite inhibitrice vis-a-vis de nos
EP1902733A1 (fr) * 2006-09-19 2008-03-26 Laboratorios Del Dr. Esteve, S.A. Combinaison de substances actives comporant un ligand de récepteur NMDA et un composé a affinité de récepteur 5-HT6
EP1953141A1 (fr) * 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Sulfamides substitués d'aryl pour le traitement des maladies cognitives ou d'ingestion de la nourriture
EP1953153A1 (fr) * 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Sulfamides substitués d'hétérocyclyle pour le traitement des maladies cognitives ou d'ingestion de la nourriture
EP2018861A1 (fr) * 2007-07-26 2009-01-28 Laboratorios del Dr. Esteve S.A. Ligands 5HT6 comme des dérivés de sulfonamides liés à la prise de poids médicamenteuse
ATE495737T1 (de) 2007-08-01 2011-02-15 Esteve Labor Dr Kombination von mindestens zwei 5-ht6-liganden
EP2036888A1 (fr) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Sulfonamides à substitution naphtyl
JP2011503120A (ja) * 2007-11-16 2011-01-27 ニューラクソン，インコーポレーテッド 内臓痛を治療するためのインドール化合物および方法
MX2010005343A (es) * 2007-11-16 2010-08-09 Neuraxon Inc Compuestos indola 3, 5-sustituidos que tienen actividad inhibidora de la re-absorcion y el reciclo de nos y norepinefrina.
US20090163451A1 (en) * 2007-11-16 2009-06-25 Frank Porreca Methods for treating visceral pain
EP2116547A1 (fr) 2008-05-09 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. Dérivés de n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide substitués en tant que ligands 5-ht6
EP2116546A1 (fr) * 2008-05-09 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. Dérivés de N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide substitués en tant que ligands 5-HT6
AU2014298017B2 (en) * 2013-08-02 2018-03-29 Pfizer Inc. Heterobicycloaryl RORC2 inhibitors and methods of use thereof
MA40759A (fr) 2014-09-26 2017-08-01 Pfizer Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472870A (en) 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
NZ305166A (en) * 1995-03-20 1998-12-23 Lilly Co Eli 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments
US5962473A (en) * 1996-08-16 1999-10-05 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
EP0875513A1 (fr) * 1997-04-14 1998-11-04 Eli Lilly And Company Composés hétéroaromatiques substitués agonistes du récepteur 5-HT1F
US6380201B1 (en) * 1997-08-05 2002-04-30 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists
ES2187300B1 (es) * 2001-11-14 2004-06-16 Laboratorios Del Dr. Esteve, S.A. Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.

Also Published As

Publication number Publication date
ES2259387T3 (es) 2006-10-01
EP1666462A1 (fr) 2006-06-07
SI1445252T1 (sl) 2006-06-30
MXPA04004601A (es) 2004-08-13
ES2322068T3 (es) 2009-06-16
ES2187300A1 (es) 2003-05-16
US20030191124A1 (en) 2003-10-09
TWI275585B (en) 2007-03-11
NZ533136A (en) 2006-01-27
ECSP045105A (es) 2004-07-23
ZA200404073B (en) 2006-05-31
US7452881B2 (en) 2008-11-18
US20050032791A1 (en) 2005-02-10
IS8698A (is) 2007-12-05
CA2466965A1 (fr) 2003-05-22
JP2005513016A (ja) 2005-05-12
IL161885A0 (en) 2005-11-20
HUP0402317A2 (hu) 2005-02-28
ATE428694T1 (de) 2009-05-15
PL373894A1 (en) 2005-09-19
DE60209779D1 (de) 2006-05-04
RS41104A (sr) 2006-10-27
CN1271052C (zh) 2006-08-23
PT1445252E (pt) 2006-07-31
PT1666462E (pt) 2009-05-07
NZ543393A (en) 2007-04-27
DE60209779T2 (de) 2006-11-16
SG146442A1 (en) 2008-10-30
TW200407306A (en) 2004-05-16
ES2249129B2 (es) 2007-08-16
US7105515B2 (en) 2006-09-12
US7498328B2 (en) 2009-03-03
CA2466965C (fr) 2011-09-06
ES2187300B1 (es) 2004-06-16
KR20040071685A (ko) 2004-08-12
UA78252C2 (en) 2007-03-15
US20070167448A1 (en) 2007-07-19
DE60232029D1 (de) 2009-05-28
ES2249129A1 (es) 2006-03-16
JP2009298819A (ja) 2009-12-24
EP1666462B1 (fr) 2009-04-15
HK1070053A1 (en) 2005-06-10
ATE319684T1 (de) 2006-03-15
RU2005136355A (ru) 2007-05-27
CN1599718A (zh) 2005-03-23
NO20042478L (no) 2004-08-12
RU2004117850A (ru) 2005-11-20
IL193234A0 (en) 2009-02-11
EP1445252A1 (fr) 2004-08-11
EP1445252B1 (fr) 2006-03-08
CO5590895A2 (es) 2005-12-30
WO2003042175A1 (fr) 2003-05-22
US7176200B2 (en) 2007-02-13
HRP20040429A2 (en) 2005-06-30
IS7263A (is) 2004-05-13
CY1105362T1 (el) 2010-03-03
US20060258653A1 (en) 2006-11-16
JP4416505B2 (ja) 2010-02-17
BR0214243A (pt) 2004-12-21
HRP20040429B1 (hr) 2007-10-31
AR037288A1 (es) 2004-11-03
JP5132649B2 (ja) 2013-01-30
DK1445252T3 (da) 2006-06-19
RU2293082C2 (ru) 2007-02-10

Similar Documents

Publication Publication Date Title
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
MA27427A1 (fr) Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
RU2325389C2 (ru) Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью
ATE402929T1 (de) Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
TNSN07476A1 (fr) Derives de n-(pyridine -2- yl) - sulfonamide
IS6647A (is) Kínasólínafleiður til að meðhöndla æxli
EP1819227A4 (fr) Formulation pharmaceutique de decitabine
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
EE200200207A (et) Kinoliiniderivaatide kasutamine vähivastase ravimi valmistamiseks, ühendite saamine ning neid sisaldavad farmatseutilised kompositsioonid
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
SE0001899D0 (sv) New compounds
BR0212078A (pt) Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
TR200001542T2 (tr) Mide fundusunu gevşetici özelliklere sahip (benzodioksan, benzofuran veya benzopiran) türevleri.
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
MA56883B1 (fr) Dérivés de 2-hydroxycycloalcane-1-carbamoyle
TNSN06439A1 (fr) Derives de 2-carbamide -4-phenylthiazole, leur preparation et leur application en therapeutique
MA29213B1 (fr) Quinolones a substitution macrolones - amino
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
MA28742B1 (fr) Derives de pyrido-pyrimidine, leur preparation, leur application en therapeutique
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
DE69718734D1 (de) Bicyclische aromatische verbindungen
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
SE9903894D0 (sv) Novel compounds